Related references
Note: Only part of the references are listed.In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling
B. Casar et al.
ONCOGENE (2014)
SLAP displays tumour suppressor functions in colorectal cancer via destabilization of the SRC substrate EPHA2
Cecile Naudin et al.
NATURE COMMUNICATIONS (2014)
Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
Abdullah Alajati et al.
CANCER RESEARCH (2013)
Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis
Takamasa Uekita et al.
CANCER SCIENCE (2011)
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma
Hui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration
Olga V. Razorenova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CUB Domain-Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
Yuri Miyazawa et al.
CANCER RESEARCH (2010)
Tyrosine Phosphorylation Profiling Reveals the Signaling Network Characteristics of Basal Breast Cancer Cells
Falko Hochgraefe et al.
CANCER RESEARCH (2010)
Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization
A. Sirvent et al.
ONCOGENE (2010)
Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells
Cedric Leroy et al.
CANCER RESEARCH (2009)
Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung
Jun-ichiro Ikeda et al.
CANCER SCIENCE (2009)
Phosphorylation of the src Epithelial Substrate Trask Is Tightly Regulated in Normal Epithelia but Widespread in Many Human Epithelial Cancers
Ching Hang Wong et al.
CLINICAL CANCER RESEARCH (2009)
T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance
Robert J. Salmond et al.
IMMUNOLOGICAL REVIEWS (2009)
The Cell Surface Glycoprotein CDCP1 in Cancer-Insights, Opportunities, and Challenges
Andreas Wortmann et al.
IUBMB LIFE (2009)
Src kinases as therapeutic targets for cancer
Lori C. Kim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model
Amara C. Siva et al.
CANCER RESEARCH (2008)
The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src
Chitose Oneyama et al.
MOLECULAR CELL (2008)
Epigenetic regulation of the expression of the novel stem cell marker CDCP 1 in cancer cells
J-i Ikeda et al.
JOURNAL OF PATHOLOGY (2006)
The C2 domain of PKCδ is a phosphotyrosine binding domain
CH Benes et al.
CELL (2005)
Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia
TA Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin
R Verma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes
G Manes et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
